Acute Pain

Latest

Arthroscopic Shoulder Surgery Outcomes With Preoperative Opioid Use

By

Nicole Clemons

Patients who use opioids preoperatively may achieve improvements in outcomes after arthroscopic shoulder surgery, but opioid use may negatively affect satisfaction levels.

Nitrous Oxide Safe and Effective for Labor Analgesia

Nitrous oxide (N2O) is a useful, safe option for labor analgesia.

Choice of Spinal Anesthesia Key to Early Ambulation After THA

MEP spinal anesthesia allows for earlier ambulation for patients undergoing total hip arthroplasty.

Pectoralis Nerve Blocks Reduce Pain After Pacemaker, ICD Placement

By

Morgan E. Meissner

Pectoral nerve blocks were found to diminish pain and opioid use following pacemaker or implantable cardioverter defibrillator placement in children.

Anesthesia Procedure Outlined for Emergency Surgery in Those With COVID-19

Recommendations are presented regarding anesthesia procedures for emergency operations in patients with suspected or confirmed COVID-19.

Can Therapeutic Alternatives Reduce Postoperative Opioid Dependence?

By

Alyssa Capel

Managing moderate or severe postoperative pain, which affects 75% of patients in the United States, remains a challenge for physicians.

FDA Accepts Bupivacaine HCL Collagen Matrix NDA for Postsurgical Pain

By

Brian Park, PharmD

The FDA has accepted the resubmitted NDA for XaraColl® for the management of postsurgical pain after open inguinal hernia surgery.

Multipronged Postop Opioid Program Reduces Prescription Length

A systemwide, multipronged pain management and opioid reduction program can significantly reduce opioid discharge prescriptions written for more than five days.

FDA Approves Meloxicam Injection for Moderate to Severe Pain

By

Diana Ernst, RPh

The FDA has approved Anjeso (meloxicam injection; Baudax Bio) for the management of moderate to severe pain, alone or in combination with NSAIDs in adult patients.

FDA Approves OTC Switch of Diclofenac Topical Gel

By

Diana Ernst, RPh

Diclofenac sodium topical gel and olopatadine HCl ophthalmic drops will soon be available over-the-counter (OTC) after the the Food and Drug Administration (FDA) switched the status of these products from prescription to nonprescription.